Skip to content
ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies

Innovative vaccines for a healthier world

  • Company
    • About us
    • Disease focus
    • AdaptVac
    • Investors & Partners
  • Platform
  • Pipeline
    • Overview
    • ES2B-C001
  • CRO
  • Media
    • Press releases
    • Events
    • Multimedia
    • Publications
  • Investors
  • Careers

Presentation of 2024 first quarter results

  • Home
  • Events
  • Presentation of 2024 first quarter results
Presentation of 2024 first quarter results
Presentation of 2024 first quarter results
favorite_border
  • iCal Export
  • Google Calendar
  • Outlook 365
  • Outlook Live
16 May 10:00 AM

Presentation of 2024 first quarter results

Virtual
  • Details
  • Weather
  • Other Events
Presentation of 2024 first quarter results
Virtual

No data found.

ExpreS2ion CEO Bent Frandsen and CFO Keith Alexander will present the 2024 first quarter results and answer investors’ questions. More information and registration can be found on the H.C. Andersen Capital Events website.

Scan QR Code

Post navigation

Biostock Global Forum
Immune-Oncology Summit Europe

Copyright 2010 - All Rights Reserved

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark
Contact:
info@expres2ionbio.com
+45 22 22 10 19

Holding Company
ExpreS2ion Biotech Holding AB:
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

Investor relations:
investor@expres2ionbio.com
Partnering:
partnering@expres2ionbio.com
Reagents and kits:
sales@expres2ionbio.com

More info:
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 ExpreS2ion Biotechnologies All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.